1-4 of 4
John H. Griffin
Close
Sort by
Journal Articles

Biased agonism of protease-activated receptor-1 regulates thromboinflammation in murine sickle cell disease

Nirupama Ramadas, Kailyn Lowder, Joshua Dutton, Fatima Trebak, Camille Faes, John H. Griffin, Rafal Pawlinski, Laurent O. Mosnier, Erica Sparkenbaugh
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3272–3283.
https://doi.org/10.1182/bloodadvances.2023011907
Published: 2024
Includes: Supplemental data
Journal Articles

Thrombin-mediated activation of PAR1 enhances doxorubicin-induced cardiac injury in mice

Steven P. Grover, Vanthana Bharathi, Jens J. Posma, John H. Griffin, Joseph S. Palumbo, Nigel Mackman, Silvio Antoniak
Journal: Blood Advances
Blood Adv (2023) 7 (10): 1945–1953.
https://doi.org/10.1182/bloodadvances.2022008637
Published: 2023
Journal Articles

An engineered factor Va prevents bleeding induced by direct-acting oral anticoagulants by different mechanisms

Annette von Drygalski, Vikas Bhat, Andrew J. Gale, Patricia M. Averell, Thomas J. Cramer, Darlene J. Elias, John H. Griffin, Laurent O. Mosnier
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3716–3727.
https://doi.org/10.1182/bloodadvances.2020001699
Published: 2020
Includes: Supplemental data
Journal Articles

Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S

José A. Fernández, Xiao Xu, Ranjeet K. Sinha, Laurent O. Mosnier, Michel F. Sanner, John H. Griffin
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1423–1426.
https://doi.org/10.1182/bloodadvances.2017007005
Published: 2017
Includes: Supplemental data